Temsirolimus as Second-line Therapy in HCC

Clinical trial NCT01567930 · UNKNOWN

Trial details

NCT number

NCT01567930

Sponsor

University of Tennessee Cancer Institute

Status

UNKNOWN

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2010-02-01

Primary completion

2012-12-01

Enrollment

25

View on ClinicalTrials.gov